These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10858627)

  • 1. Decreased S100-beta protein in schizophrenia: preliminary evidence.
    Gattaz WF; Lara DR; Elkis H; Portela LV; Gonçalves CA; Tort AB; Henna J; Souza DO
    Schizophr Res; 2000 Jun; 43(2-3):91-5. PubMed ID: 10858627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased calcium-independent lipoprotein phospholipase A2 but not protein S100 in patients with schizophrenia.
    Šakić M; Karlović D; Vidrih B; Peitl V; Crnković D; Vrkić N
    Psychiatr Danub; 2016 Mar; 28(1):45-50. PubMed ID: 26938821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma levels of S-100b protein in schizophrenic patients.
    Wiesmann M; Wandinger KP; Missler U; Eckhoff D; Rothermundt M; Arolt V; Kirchner H
    Biol Psychiatry; 1999 Jun; 45(11):1508-11. PubMed ID: 10356634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum S100B in never-medicated and medicated schizophrenic patients.
    Zhang XY; Xiu MH; Song C; Chen DC; Wu GY; Haile CN; Kosten TA; Kosten TR
    J Psychiatr Res; 2010 Dec; 44(16):1236-40. PubMed ID: 20510426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do changes in S100beta protein correlate with serum magnesium concentrations in patients undergoing extracorporeal circulation?
    Dabrowski W
    Magnes Res; 2007 Sep; 20(3):168-76. PubMed ID: 17972459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100 and S100β: biomarkers of cerebral damage in cardiac surgery with or without the use of cardiopulmonary bypass.
    Yuan SM
    Rev Bras Cir Cardiovasc; 2014; 29(4):630-41. PubMed ID: 25714218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.
    Ross BM; Hudson C; Erlich J; Warsh JJ; Kish SJ
    Arch Gen Psychiatry; 1997 May; 54(5):487-94. PubMed ID: 9152103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium supplementation significantly reduces serum S100beta concentrations in patients who have undergone coronary artery bypass surgery.
    Dabrowski W
    Magnes Res; 2009 Mar; 22(1):21-31. PubMed ID: 19441271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Levels of S100β protein in patients with mild traumamic brain injury].
    Talypov AE; Puras IuV; Godkov MA; Sharifullin FA; Kuksova NS; Sosnovskiĭ EA; Krylov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):4-8. PubMed ID: 21311479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordant temporal patterns of S100beta and cleaved tau protein elevation after head injury: a pilot study.
    Chatfield DA; Zemlan FP; Day DJ; Menon DK
    Br J Neurosurg; 2002 Oct; 16(5):471-6. PubMed ID: 12498491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum S100beta increases in marathon runners reflect extracranial release rather than glial damage.
    Hasselblatt M; Mooren FC; von Ahsen N; Keyvani K; Fromme A; Schwarze-Eicker K; Senner V; Paulus W
    Neurology; 2004 May; 62(9):1634-6. PubMed ID: 15136701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions.
    Kanner AA; Marchi N; Fazio V; Mayberg MR; Koltz MT; Siomin V; Stevens GH; Masaryk T; Aumayr B; Vogelbaum MA; Barnett GH; Janigro D
    Cancer; 2003 Jun; 97(11):2806-13. PubMed ID: 12767094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity.
    Vos PE; van Gils M; Beems T; Zimmerman C; Verbeek MM
    Eur J Neurol; 2006 Jun; 13(6):632-8. PubMed ID: 16796588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining serum protein concentrations to diagnose schizophrenia: a preliminary exploration.
    Xiong P; Zeng Y; Wu Q; Han Huang DX; Zainal H; Xu X; Wan J; Xu F; Lu J
    J Clin Psychiatry; 2014 Aug; 75(8):e794-801. PubMed ID: 25191916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophrenia.
    Dean B; Gray L; Scarr E
    Aust N Z J Psychiatry; 2006 Mar; 40(3):217-24. PubMed ID: 16476148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy.
    Gattaz WF; Köllisch M; Thuren T; Virtanen JA; Kinnunen PK
    Biol Psychiatry; 1987 Apr; 22(4):421-6. PubMed ID: 3567258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of the S100β protein as a marker of brain damage in traumatic brain injury.
    Egea-Guerrero JJ; Revuelto-Rey J; Murillo-Cabezas F; Muñoz-Sánchez MA; Vilches-Arenas A; Sánchez-Linares P; Domínguez-Roldán JM; León-Carrión J
    Brain Inj; 2012; 26(1):76-82. PubMed ID: 22149446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia.
    Rothermundt M; Ponath G; Glaser T; Hetzel G; Arolt V
    Neuropsychopharmacology; 2004 May; 29(5):1004-11. PubMed ID: 14997170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum phospholipase A2 activity in schizophrenia: a replication study.
    Gattaz WF; Hübner CV; Nevalainen TJ; Thuren T; Kinnunen PK
    Biol Psychiatry; 1990 Sep; 28(6):495-501. PubMed ID: 2223919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral markers of brain damage and blood-brain barrier dysfunction.
    Marchi N; Rasmussen P; Kapural M; Fazio V; Kight K; Mayberg MR; Kanner A; Ayumar B; Albensi B; Cavaglia M; Janigro D
    Restor Neurol Neurosci; 2003; 21(3-4):109-21. PubMed ID: 14530574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.